MassMutual Private Wealth & Trust’s Tarsus Pharmaceuticals TARS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.92K	Hold	110	–	–	﹤0.01%	1560
2026 Q1	$7.72K	Hold	110	–	–	﹤0.01%	1479
2025 Q4	$9.01K	Sell	110 -26	-19%	-$1.94K	﹤0.01%	1433
2025 Q3	$8.08K	Sell	136 -44	-24%	-$2.17K	﹤0.01%	1478
2025 Q2	$7.29K	Sell	180 -30	-14%	-$1.35K	﹤0.01%	1484
2025 Q1	$10.8K	Buy	+210	New	+$10.4K	﹤0.01%	1283
2023 Q2	–	Sell	-95	Closed	-$1.19K	–	2013
2023 Q1	$1.19K	Hold	95	–	–	﹤0.01%	1551
2022 Q4	$1K	Buy	95 +72	+313%	+$1.19K	﹤0.01%	1551
2022 Q3	$0	Buy	+23	New	+$365	﹤0.01%	1810

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MassMutual Private Wealth & Trust's TARS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 110 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

MassMutual Private Wealth & Trust first reported a position in TARS in Q3 2022 and has held it in 9 quarters since. The position peaked at $10.8K in Q1 2025. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

MassMutual Private Wealth & Trust held 110 shares of Tarsus Pharmaceuticals worth $6.92K as of Q2 2026.
MassMutual Private Wealth & Trust left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
Tarsus Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1560 holding.
MassMutual Private Wealth & Trust first reported a position in Tarsus Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
MassMutual Private Wealth & Trust's Tarsus Pharmaceuticals position peaked at $10.8K in Q1 2025.
256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.